Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric carboxymaltose phosphate safety study in pregnant women with anaemia
ACTRN12623000787684Phase 4Completed
- Sponsor
- Training and Research Unit of Excellence
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ferric carboxymaltose in anaemia and iron deficiency anemia (IDA), sponsored by Training and Research Unit of Excellence. Primary endpoint: Nadir serum phosphate concentration. Started Aug 2023; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
anaemiairon deficiency anemia (IDA)
Beyond the preview
Go deeper on ACTRN12623000787684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000787684.